Maliqi, Liridona
Friedrich, Nikolas http://orcid.org/0000-0003-0694-657X
Glögl, Matthias
Schmutz, Stefan
Schmidt, Daniel
Rusert, Peter
Schanz, Merle
Zaheri, Maryam
Pasin, Chloé
Niklaus, Cyrille
Foulkes, Caio
Reinberg, Thomas
Dreier, Birgit
Abela, Irene
Peterhoff, David
Hauser, Alexandra
Kouyos, Roger D.
Günthard, Huldrych F. http://orcid.org/0000-0002-1142-6723
van Gils, Marit J. http://orcid.org/0000-0003-3422-8161
Sanders, Rogier W. http://orcid.org/0000-0002-2324-8573
Wagner, Ralf
Plückthun, Andreas http://orcid.org/0000-0003-4191-5306
Trkola, Alexandra http://orcid.org/0000-0003-1013-876X
Article History
Received: 12 April 2023
Accepted: 19 September 2023
First Online: 30 September 2023
Competing interests
: A.P. is a cofounder and shareholder of Molecular Partners AG who are developing DARPins as therapeutics. The other authors declare no competing financial interests.